Intellia Therapeutics Inc (NTLA) Insider Trading
- $13,217,886.00
- $277,609,497.39
- Oct. 2, 2024
- John M Leonard
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 2, 2024 | CAO | 2,012 | $19.01 | Sell | $38,248.12 | |
July 1, 2024 | EVP | 405 | $22.93 | Sell | $9,286.65 | |
March 4, 2024 | EVP | 2,297 | $32.99 | Sell | $75,778.03 | |
Jan. 8, 2024 | EVP | 2,275 | $28.87 | Sell | $65,679.25 | |
Jan. 3, 2024 | CFO | 5,365 | $29.46 | Sell | $158,052.90 | |
Jan. 3, 2024 | EVP | 5,843 | $29.46 | Sell | $172,134.78 | |
Jan. 3, 2024 | CEO | 19,223 | $29.46 | Sell | $566,309.58 | |
Oct. 31, 2023 | Director | 265 | $23.90 | Sell | $6,333.50 | |
July 31, 2023 | Director | 265 | $42.33 | Sell | $11,217.45 | |
July 6, 2023 | Director | 1,867 | $39.30 | Sell | $73,373.10 | |
July 3, 2023 | EVP | 360 | $40.51 | Sell | $14,583.60 | |
June 20, 2023 | EVP | 5,000 | $45.00 | Sell | $225,000.00 | |
Jan. 4, 2023 | CEO | 6,673 | $37.21 | Sell | $248,302.33 | |
Jan. 4, 2023 | CFO | 2,427 | $37.21 | Sell | $90,308.67 | |
Jan. 4, 2023 | EVP | 2,508 | $37.21 | Sell | $93,322.68 | |
Jan. 1, 2022 | CFO | 1,013 | $112.24 | Sell | $113,699.12 | |
Jan. 1, 2022 | EVP | 1,148 | $112.25 | Sell | $128,863.00 | |
Jan. 1, 2022 | CEO | 2,493 | $112.25 | Sell | $279,839.25 | |
Nov. 5, 2021 | EVP | 2,400 | $132.72 | Sell | $318,528.00 | |
Oct. 14, 2021 | EVP | 2,400 | $128.44 | Sell | $308,256.00 | |
Oct. 11, 2021 | Director | 2,500 | $119.55 | Sell | $298,875.00 | |
Oct. 5, 2021 | Director | 10,000 | $130.54 | Sell | $1,305,400.00 | |
Sept. 21, 2021 | EVP | 2,400 | $149.81 | Sell | $359,544.00 | |
Sept. 7, 2021 | CFO | 3,482 | $180.12 | Sell | $627,177.84 | |
Sept. 1, 2021 | CEO | 44,735 | $170.00 | Sell | $7,604,950.00 | |
Aug. 31, 2021 | CFO | 24,800 | $160.22 | Sell | $3,973,456.00 | |
Aug. 30, 2021 | CEO | 38,804 | $155.95 | Sell | $6,051,483.80 | |
Aug. 30, 2021 | EVP | 97,000 | $154.83 | Sell | $15,018,510.00 | |
Aug. 19, 2021 | CEO | 22,682 | $151.28 | Sell | $3,431,332.96 | |
Aug. 9, 2021 | EVP | 2,400 | $164.05 | Sell | $393,720.00 | |
Aug. 5, 2021 | CFO | 20,000 | $151.05 | Sell | $3,021,000.00 | |
Aug. 4, 2021 | EVP | 26,000 | $138.24 | Sell | $3,594,240.00 | |
June 28, 2021 | Director | 553,376 | $132.73 | Sell | $73,449,596.48 | |
June 14, 2021 | Director | 170,779 | $87.37 | Sell | $14,920,961.23 | |
June 11, 2021 | Director | 30,946 | $85.23 | Sell | $2,637,527.58 | |
April 28, 2021 | Director | 131,926 | $85.56 | Sell | $11,287,588.56 | |
April 26, 2021 | Director | 806 | $84.93 | Sell | $68,453.58 | |
April 5, 2021 | Director | 7,500 | $82.19 | Sell | $616,425.00 | |
April 1, 2021 | CEO | 38,209 | $83.64 | Sell | $3,195,800.76 | |
April 1, 2021 | EVP | 50,455 | $82.46 | Sell | $4,160,519.30 | |
Feb. 26, 2021 | Director | 501,945 | $60.29 | Sell | $30,262,264.05 | |
Feb. 9, 2021 | CEO | 28,043 | $75.00 | Sell | $2,103,225.00 | |
Feb. 9, 2021 | EVP | 11,489 | $75.00 | Sell | $861,675.00 | |
Feb. 5, 2021 | CEO | 22,942 | $67.66 | Sell | $1,552,255.72 | |
Feb. 3, 2021 | CEO | 67,856 | $72.54 | Sell | $4,922,274.24 | |
Feb. 1, 2021 | CEO | 109,889 | $64.00 | Sell | $7,032,896.00 | |
Feb. 1, 2021 | EVP | 54,659 | $63.99 | Sell | $3,497,629.41 | |
Jan. 5, 2021 | CEO | 6,239 | $55.86 | Sell | $348,510.54 | |
Jan. 5, 2021 | COO | 1,377 | $55.86 | Sell | $76,919.22 | |
Jan. 5, 2021 | EVP | 2,078 | $55.86 | Sell | $116,077.08 |
Insiders are both buying and selling Intellia Therapeutics Inc stock.
The insider traders at Intellia Therapeutics Inc are: John M Leonard, Jean Francois Formela, Jose E Rivera, Glenn Goddard, Laura Sepp-Lorenzino, David Lebwohl, Jose E. Rivera, Eliana Clark, Muna Bhanji, Andrew Schiermeier, Institutes For Biomed Novartis, John F Crowley, John M. Leonard, Nessan Bermingham, Caroline Dorsa, Carl L Gordon, Caribou Biosciences, Inc., Michael P Dube, Bros. Advisors Lp Baker, Venture Fund Ix L.P. Atlas, James Basta, and Perry A Karsen
The most active insider trader at Intellia Therapeutics Inc is John M Leonard with 19 trades.
Jean Francois Formela has sold the most Intellia Therapeutics Inc stock with a total value of $207,869,472.85.
Institutes For Biomed Novartis has bought the most Intellia Therapeutics Inc stock with a total value of $9,999,972.00.
The most recent insider trade for Intellia Therapeutics Inc was on Oct. 2, 2024.
The single biggest insider buy for Intellia Therapeutics Inc was from Institutes For Biomed Novartis with a total value of $4,999,986.00 on May 11, 2016.
The single biggest insider sell for Intellia Therapeutics Inc was from Jean Francois Formela with a total value of $73,449,596.48 on June 28, 2021.